L. Roy Papp & Associates LLP Acquires 359 Shares of Mettler-Toledo International, Inc. $MTD

L. Roy Papp & Associates LLP boosted its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 3.6% during the second quarter, Holdings Channel.com reports. The fund owned 10,242 shares of the medical instruments supplier’s stock after buying an additional 359 shares during the quarter. Mettler-Toledo International accounts for 1.4% of L. Roy Papp & Associates LLP’s investment portfolio, making the stock its 19th largest holding. L. Roy Papp & Associates LLP’s holdings in Mettler-Toledo International were worth $12,031,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Farther Finance Advisors LLC increased its stake in Mettler-Toledo International by 39.1% in the 1st quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier’s stock worth $103,000 after acquiring an additional 25 shares during the last quarter. QRG Capital Management Inc. increased its stake in Mettler-Toledo International by 29.4% in the 1st quarter. QRG Capital Management Inc. now owns 489 shares of the medical instruments supplier’s stock worth $577,000 after acquiring an additional 111 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its stake in Mettler-Toledo International by 13.3% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,488 shares of the medical instruments supplier’s stock worth $2,929,000 after acquiring an additional 292 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in Mettler-Toledo International by 95.0% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier’s stock worth $2,600,000 after acquiring an additional 1,073 shares during the last quarter. Finally, Boston Trust Walden Corp increased its stake in Mettler-Toledo International by 7.1% in the 1st quarter. Boston Trust Walden Corp now owns 34,610 shares of the medical instruments supplier’s stock worth $40,871,000 after acquiring an additional 2,296 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, insider Gerry Keller sold 165 shares of the firm’s stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the transaction, the insider directly owned 94 shares in the company, valued at $123,012.16. This trade represents a 63.71% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Shawn Vadala sold 300 shares of the stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total value of $376,227.00. Following the completion of the sale, the chief financial officer owned 5,095 shares of the company’s stock, valued at approximately $6,389,588.55. This trade represents a 5.56% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,827 shares of company stock worth $2,371,208 in the last ninety days. 1.94% of the stock is owned by insiders.

Mettler-Toledo International Price Performance

MTD opened at $1,307.98 on Friday. The stock’s 50 day simple moving average is $1,277.46 and its 200 day simple moving average is $1,189.50. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,486.76. The firm has a market cap of $26.94 billion, a price-to-earnings ratio of 33.12, a PEG ratio of 3.99 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. During the same period last year, the company earned $9.65 EPS. Mettler-Toledo International’s revenue for the quarter was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have weighed in on MTD shares. Weiss Ratings restated a “hold (c)” rating on shares of Mettler-Toledo International in a research note on Wednesday. JPMorgan Chase & Co. increased their price objective on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research report on Thursday. Barclays increased their price objective on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a research report on Thursday, October 2nd. Robert W. Baird increased their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research report on Monday, August 4th. Finally, Bank of America increased their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research report on Monday, September 22nd. Five equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $1,336.50.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.